Breast cancer
Results
Phase 3
This trial looked at a drug called everolimus alongside trastuzumab (Herceptin) and chemotherapy for breast cancer that has spread to another part of the body. The trial was for women with breast cancer that has large amounts of the protein (HER2 positive).
Recruitment start: 26 October 2009
Recruitment end: 23 May 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Perren
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Novartis
Last reviewed: 04 Aug 2016
CRUK internal database number: 4157
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
